Profiling Thiol Metabolites and Quantification of Cellular Glutathione Using FT-ICR-MS Spectrometry by Gori, Sadakatali S. et al.
University of Kentucky
UKnowledge
Toxicology and Cancer Biology Faculty
Publications Toxicology and Cancer Biology
7-2014
Profiling Thiol Metabolites and Quantification of
Cellular Glutathione Using FT-ICR-MS
Spectrometry
Sadakatali S. Gori
University of Louisville
Pawel Lorkiewicz
University of Louisville
Daniel S. Ehringer
University of Louisville
Alex C. Belshoff
University of Louisville
Richard M. Higashi
University of Kentucky, rick.higashi@uky.edu
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/toxicology_facpub
Part of the Medical Toxicology Commons
This Article is brought to you for free and open access by the Toxicology and Cancer Biology at UKnowledge. It has been accepted for inclusion in
Toxicology and Cancer Biology Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Repository Citation
Gori, Sadakatali S.; Lorkiewicz, Pawel; Ehringer, Daniel S.; Belshoff, Alex C.; Higashi, Richard M.; Fan, Teresa W-M; and Nantz,
Michael H., "Profiling Thiol Metabolites and Quantification of Cellular Glutathione Using FT-ICR-MS Spectrometry" (2014).
Toxicology and Cancer Biology Faculty Publications. 44.
https://uknowledge.uky.edu/toxicology_facpub/44
Authors
Sadakatali S. Gori, Pawel Lorkiewicz, Daniel S. Ehringer, Alex C. Belshoff, Richard M. Higashi, Teresa W-M
Fan, and Michael H. Nantz
Profiling Thiol Metabolites and Quantification of Cellular Glutathione Using FT-ICR-MS Spectrometry
Notes/Citation Information
Published in Analytical and Bioanalytical Chemistry, v. 406, no. 18, p. 4371-4379.
© Springer-Verlag Berlin Heidelberg 2014
The copyright holder has granted the permission for posting the article here.
The document available for download is the authors' post-peer-review final draft of the article. The final
publication is available at Springer via http://dx.doi.org/10.1007/s00216-014-7810-z
Digital Object Identifier (DOI)
http://dx.doi.org/10.1007/s00216-014-7810-z
This article is available at UKnowledge: https://uknowledge.uky.edu/toxicology_facpub/44
  
 
© Springer-Verlag Berlin Heidelberg 
2014 
 
The final publication is available at 
Springer via 
http://dx.doi.org/10.1007/s00216-014-
7810-z 
 
Profiling thiol metabolites and quantification of cellular
glutathione using FT-ICR-MS spectrometry
Sadakatali S. Gori,
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA
Pawel Lorkiewicz,
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA, Center for
Regulatory and Environmental Analytical Metabolomics (CREAM), University of Louisville,
Louisville, KY 40292, USA
Daniel S. Ehringer,
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA
Alex C. Belshoff,
Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA
Richard M. Higashi,
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA, Center for
Regulatory and Environmental Analytical Metabolomics (CREAM), University of Louisville,
Louisville, KY 40292, USA, Graduate Center of Toxicology and Markey Cancer Center, University
of Kentucky, Lexington, KY 40536, USA
Teresa W.-M. Fan, and
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA, Center for
Regulatory and Environmental Analytical Metabolomics (CREAM), University of Louisville,
Louisville, KY 40292, USA, Graduate Center of Toxicology and Markey Cancer Center, University
of Kentucky, Lexington, KY 40536, USA
Michael H. Nantz
Department of Chemistry, University of Louisville, Louisville, KY 40292, USA
Teresa W.-M. Fan: t.fan@uky.edu; Michael H. Nantz: michael.nantz@louisville.edu
Abstract
We describe preparation and use of the quaternary ammonium-based α-iodoacetamide QDE and
its isotopologue *QDE as reagents for chemoselective derivatization of cellular thiols. Direct
addition of the reagents to live cells followed by adduct extraction into n-butanol and analysis by
FT-ICR-MS provided a registry of matched isotope peaks from which molecular formulae of thiol
metabolites were derived. Acidification to pH 4 during cell lysis and adduct formation further
improves the chemoselectivity for thiol derivatization. Examination of A549 human lung
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adenocarcinoma cells using this approach revealed cysteine, cysteinylglycine, glutathione, and
homocysteine as principal thiol metabolites as well as the sulfinic acid hypotaurine. The method is
also readily applied to quantify the thiol metabolites, as demonstrated here by the quantification of
both glutathione and glutathione disulfide in A549 cells at concentrations of 34.4±11.5 and 10.1±
4.0 nmol/mg protein, respectively.
Keywords
Chemoselective; Metabolomics; Iodoacetamide; Hypotaurine; Oxidative stress; Cysteine
Introduction
Cellular thiol-containing metabolites, such as cysteine and glutathione, are crucially
important for maintaining and regulating redox homeostasis in addition to protein functions
[1, 2]. For example, the reduced form of cellular glutathione (GSH) is oxidized to its dimer
glutathione disulfide (GSSG) in response to oxidative stress as a means to minimize cellular
damage from reactive oxygen species [3, 4]. Since many diseases are linked to high levels of
oxidative stress, the intracellular levels of GSH and GSSG can be indicative of cell
pathogenesis [5–7]. Indeed, studying the ratio of GSH to GSSG and quantifying the
dysregulation of GSH and GSSG levels are keys to understanding oxidative stress and the
etiology of many important human diseases including cancer and type 2 diabetes [8–10]. To
profile cellular thiols, chemoselective (CS) reagents for reaction with the sulfhydryl (–SH)
moiety have been developed [11, 12]. These CS approaches can enable faster as well as
more sensitive and selective analyses of thiol metabolites directly in crude extracts, and this,
in turn, can improve the understanding of metabolite roles in human disease development.
Several methods, such as fluorescent detection [13, 14], colorimetric assays [15–17],
capillary electrophoresis [18], electrochemical detection [19], SALDI-MS [20], and
chromatographic methods coupled with mass spectrometry (GC-MS [21], LC-MS [22]) have
been reported for the quantification of glutathione. The reported colorimetric and
fluorometric probes are all designed to covalently modify (i.e., tag) glutathione for detection
and quantification, and these assays also are useful for quantification of known metabolites
using reference standards. However, they are unsuited for quantifying metabolites when no
reference standards are available or in cases where isotopic tracers are employed to deduce
metabolic pathways or flux; nor can they be used for elucidating new thiol adducts
structures.
Another strategy common in proteomic as well as metabolomic studies features the
alkylation of thiol groups using isotopic reagents followed either by affinity chromatography
(e.g., biotin-avidin [23]) or liquid chromatography prior to analysis by mass spectrometry
[24, 25]. S-alkylation using reagent isotopologues in a 1:1 ratio provides thiol adducts with
nearly identical LC-MS retention times and generates isotopic peak pairs in the mass
spectrum. These methods are expressly designed to increase the dynamic range for low
abundance metabolites or low-level degradation products and to reduce ionization
suppression [26]. While these approaches are effective for thiol metabolite identification as
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well as for determination of GSH/GSSG concentrations, the reliance on separation
techniques can be tedious for high-throughput applications and in some cases unnecessary,
particularly with ultra-high resolution MS instruments [27]. Furthermore, since the
alkylations are conducted at high pH (8–9) in these approaches, the chemoselectivity for
thiols is compromised due to competing alkylations of cellular amines, phenols, and
carboxylate salts leading to false positives in the identification of cellular thiols [28]. For
applications in metabolomics, this can be a severe constraint due to interference across the
many other metabolite classes that must also be analyzed for metabolic networks.
As part of our ongoing efforts to develop reliable CS approaches for metabolite profiling
[29], we describe here a chemoselective method for the identification and quantification of
thiol metabolites by direct infusion FT-ICR-MS using GSH and GSSG as an example. The
thiol-reactive, iodoacetamide-based probe QDE (Fig. 1) was synthesized for thiol-selective
adduct formation. This probe also features a hydrophobic domain to facilitate rapid
extraction of adducts from the aqueous extracts to minimize matrix interference for accurate
quantification. Moreover, the probe contains a permanent positive charge (quaternary
ammonium moiety) to greatly enhance ionization and subsequent detection of even low
abundant thiol adducts by [+]-ion electrospray mass spectrometry. The ultra high-resolution
and accuracy mass capabilities of FT-ICR-MS enable simultaneous detection of many
thousands of metabolite ions while providing credible molecular formula information, thus
circumventing the need for chromatographic separations for the majority of metabolites. To
further streamline the detection of thiol adducts, we developed a convenient protocol that
employed both QDE and its 13CD3 isotopologue in acetonitrile to lyse cells at pH 4 or 7.4
for effectively tagging GSH and other thiol metabolites as isotopic pairs. We found that
derivatization at pH 4 improved the chemoselectivity, which together with the presence of
isotopic pairs facilitated the identification of thiol metabolites directly from crude cell
extracts. Importantly, the relatively mild conditions did not degrade non-thiol metabolites
for their simultaneous or subsequent detection.
Materials and methods
Synthesis of CS probe QDE and *QDE
QDE and *QDE (13CD3-labeled QDE) were prepared as outlined in Schemes 1 and 2,
respectively. Full experimental and characterization details are provided in the Electronic
Supplementary Material.
Optimizations of adduct formation and extraction
Optimization of QDE:thiol ratio for adduct formation—A 1:1 mixture of QDE (200
μL of a 100-μM solution in 1:1 H2O:CH3CN) and L-cysteine (200 μL of a 100-μM solution
in H2O) was prepared in a microfuge vial and agitated for 12 h in the dark at room
temperature. The reaction mixture was dried using a vacuum centrifuge and reconstituted in
1 mL MeOH. Aliquots of this solution (15 μL) were then analyzed by FT-ICR-MS. The
[QDE-Cys]+ adduct was confirmed at m/z=418.30981. The above experiment was repeated
using three equivalents of QDE per cysteine (this ratio was sufficient to completely consume
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all cysteine, as confirmed by negative mode FT-ICR-MS). Also, unreacted QDE was
observed in the spectrum.
EtOH, reflux, 24 h; b phthalimide, PPh3, DIAD, THF, 0 °C to rt, 12 h, 29 % (two steps);
c 13CD3I, 50 °C (sealed tube), 3 h; d H2NNH2·H2O, EtOH, 40 °C, 12 h, 93 % (two steps); e
chloroacetyl chloride, K2CO3, CH2Cl2, rt, 12 h; f NaI, acetone, 65 °C (sealed tube), 20 h, 32
% (two steps)
Solvent optimization for adduct extraction—A solution of L-cysteine (200 μL of a
20 mM solution in H2O) was combined with a solution of QDE (200 μL of 48-mM solution
in 1:1 H2O:CH3CN) in a microfuge vial and the resultant solution was agitated on a shaker
for 12 h in the dark at room temperature. The reaction mixture was then dried using a
vacuum centrifuge and multiply extracted (0.5 mL×5) with EtOAc. The organic layer from
each individual extraction was isolated in a separate microfuge vial and dried using a
vacuum centrifuge. Each dried extract was then reconstituted in 1 mL MeOH and vortex
mixed. One hundred microliter of each extract solution was further diluted to 1 mL with
MeOH, vortex mixed, centrifuged at 13,000 rpm for 10 min at 4 °C. Aliquots (15 μL) of the
solutions were analyzed by FT-ICR-MS. This process was repeated using the following
solvents: methylene chloride, n-butanol, toluene, chloroform, and diethyl ether.
Examination of alkylation pH—A solution of QDE (150 μL of a 10-μM solution in 1:1
H2O:CH3CN) and a solution of L-cysteine (50 μL of 10-μM solution in H2O) were added to
pH 5.8 K-phosphate buffer (100 μL) in a microfuge vial. The mixture was agitated for 12 h
at room temperature in the dark. The reaction solution was then dried using a vacuum
centrifuge and extracted with n-BuOH (0.2 mL×3). The combined extract was dried using a
vacuum centrifuge and then reconstituted in 1 mL MeOH followed by vortex mixing and
centrifugation (10 min, 130,00 rpm) at 4 °C. Aliquots (15 μL) of this solution were analyzed
by FT-ICR-MS. In similar fashion, solutions of QDE (100 μL of a 10-μM solution in 1:1
H2O:CH3CN) and L-glutathione (50 μL of a 10-μM solution in H2O) were added to pH 8 K-
phosphate buffer (100 μL) in a microfuge vial. Work-up and analysis of the reaction were
performed as described above. The reaction of cys at pH 5.8 showed that the alkylation is
possible at lower pH, whereas the reaction of GSH at pH 8.0 was carried out to evaluate
multiple alkylations by QDE.
Cell culture experimentation
The protocols for metabolic quenching, adduct formation, extraction, and quantification of
QDE-thiol adducts are summarized in Fig. 2; detailed procedures are given in the Electronic
Supplementary Material Section III.
FT-ICR-MS analyses and informatics
FT-ICR-MS analyses—A hybrid linear ion trap (LIT) FT-ICR mass spectrometer (LTQ-
FT, Thermo Electron, Bremen, Germany) equipped with a TriVersa NanoMate ion source
(Advion BioSciences, Ithaca, NY) with an “A” electrospray chip (nozzle inner diameter 5.5
μm) was used for mass spectral analysis. The TriVersa NanoMate was operated in positive
ion mode by applying 1.40 kV with 0.3 psi head pressure. MS runs were recorded over an
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m/z range from 305 to 1,000 Da using optimized ion abundance targets enabled for the
selected mass range. Initially, low-resolution LIT-MS scans were acquired for 0.50 min to
track the stability of the ion spray, after which high mass accuracy data were collected using
the FT-ICR-MS analyzer where MS scans were acquired for 14 min at a target resolving
power of m/Δm=200,000 at m/z=400 (10 % valley). Five “microscans” (ICR-MS transients)
were accumulated before Fourier transformation to produce each saved spectrum; thus the
cycle time for each transformed, saved spectrum was about 5 s. The LTQ-FT was tuned and
calibrated according to the manufacturer’s default standard recommendations, which
typically achieved better than 0.5 ppm mass accuracy at a resolving power of 200,000 at m/
z=400. FT-ICR-MS mass spectra were centroided by Xcalibur and exported as exact mass
lists into an Excel file using QualBrowser 2.0 SR2 (all software from Thermo Electron,
“Bremen” version for the LTQ-FT).
Mass corrections and global assignments of peak pairs—Peaks were exported as
numerical values of exact masses and ion counts into an Excel 2010 file and those with ion
counts less than 150 were excluded as noise. All peak pairs (m/z; m/z+ 4.02188)
representing QDE and *QDE adducts of given metabolites were selected using an in-house
program (PRecalculated Exact Mass Isotopologue Search Engine; PREMISE) [30]. Only
peak pairs with intensity ratios from 0.7 to 1.3 were used for further analyses. This list was
manually checked to ensure the accuracy of the PREMISE program. The masses were
compared across four experiments performed at both pH 4 and 7.4, and those persistently
present in at least 50 % of the experiments were retained. In the final step, (QDE—I) was
subtracted from all monoisotopic peaks and the mass of a proton was added to obtain
molecular formulae of metabolites and compared against HMDB [31, 32].
Results and discussion
CS probe design
Optimal properties of CS reagents for reaction with thiol-containing substrates include the
ability to alkylate a thiol moiety with high efficiency and selectivity while imparting
stability to the resultant adduct for subsequent MS analysis. Several reagents for derivatizing
thiol metabolites have been developed, and the most common of these contain the thiol-
reactive motifs depicted in Fig. 3. Of these, the maleimide moiety, such as in the reagent N-
ethylmaleimide (NEM) [33], is among the most reactive toward thiol groups, but its
propensity to undergo hydrolysis or transamidation after conjugation with thiol metabolites
often complicates MS analyses of the adducts [34–36]. In contrast, α-iodo carbonyl motifs,
such as in iodoacetic acid (IAA) reagents or iodoacetamide (IAM) reagents, readily alkylate
thiols via nucleophilic displacement of iodide and are comparatively stable over a wide
range of pH [37], with the IAM adducts being more robust due to the more stable amide
linkage. The IAM motif has been reported to react faster with protein thiols than the IAA
motif [38]. The drawback of these α-iodo motifs is that they react with amines and other
nucleophilic groups (albeit slowly) at higher pH and thus their chemoselectivity may be
compromised [39, 40] unless precautions are taken. Thiols also react with vinylpyridine
(VP) at its β-position to afford corresponding thioether adducts. The rate of this reaction is
considerably slower compared to thiol alkylations involving IAA, IAM, or NEM reagents
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[41, 42]. Finally, thiosulfonate-based alkylating agents, such as methyl methanethiosulfonate
(MMTS; Fig. 3), also have been used to label –SH groups; however, this approach adds
complexity to the matrix by liberating thiols during the alkylation stage as a result of
reversible disulfide formation [43, 44].
Given our aim of developing an experimentally straightforward approach for quantifying
GSH using FT-ICR-MS, and understanding that rapid alkylation of GSH is necessary to halt
any conversion to glutathione disulfide during cell lysis and subsequent analysis [45], we
selected the iodoacetamide motif as our reactive, chemoselective probe for in situ thiol
capture. In addition to this feature, our QDE probe (Fig. 1) contains a C12-hydrocarbon
chain to enhance the partitioning of [QDE-GSH]+, and other [QDE-thiol]+ adducts, into an
organic phase for rapid separation from polar, non-thiol metabolites and cellular salts. QDE
also contains a quaternary ammonium moiety as a nontitratable positive charge to greatly
improve the detection limits of QDE adducts by FT-ICR-MS. Furthermore, the ammonium
nitrogen serves as a convenient site for synthesis of stable isotope-encoded isotopologues of
QDE. We synthesized *QDE, a 13C12H3-isotopologue of QDE, in this way (Scheme 2) by
N-alkylation using labeled iodomethane. This route is amenable to the synthesis of
numerous C and H isotopologues for eventual use in multiplexed analyses by exploiting the
ultra-high resolving power of the FT-ICR-MS. For example, the availability of an m/z
(QDE) and m/z+4.02188 (*QDE) isotopic pair of reagents is key to rapid and automated
identification of thiol adducts [23]. Namely, cells treated with a 1:1 mixture of QDE and
*QDE can be expected to produce respective adducts in a similar ratio. Thus, the presence of
an equi-intensity m/z+4.02188 peak for any peak observed in the FT-ICR-MS spectrum of
the organic phase extract (c.f. §, Fig. 2) is a primary selection criterion to identify true
adducts as opposed to underivatized cell components. Finally, the availability of an
isotopically labeled probe enables the synthesis of labeled adducts for use as standards to
quantify particular thiols (e.g., quantification of GSH using [*QDE-GSH]+; see §§, Fig. 2).
CS probe reactivity
We examined several parameters for reaction of QDE with the representative biological
thiols L-glutathione and L-cysteine. Initially, reactions were performed at pH 5.8 and 8. At
pH 5.8 (potassium phosphate buffer in acetonitrile), a 3:1 molar excess of QDE to thiol
enabled the thiol to be completely consumed within 12 h at room temperature. However, at
pH 8, we also noted the bisalkylation of GSH, presumably due to GSH amine alkylation at
this pH (Fig. 4). Reactions of α-iodoacetamide reagents, such as QDE, with cellular amines
[46, 39, 40], phenols, and carboxylate salts have been noted previously under alkaline pH
conditions [28]. Although at low pH, the reaction of thiols with the α-iodoacetamide moiety
is slow [37], the chemoselectivity is very high because amine and carboxylate alkylations
are deterred. Consequently, for our cell experimentation, we implemented thiol
derivatization with QDE/*QDE at pH 4 to improve chemoselectivity for the thiol group.
Regarding adduct isolation, extensive studies with solvents revealed that n-BuOH was the
most effective solvent at extracting [QDE-thiol]+ adducts from an aqueous phase—for
example, more than 95 % of the [QDE-Cys]+ adduct was recovered within the first two
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extractions. These results closely mirror our earlier observations [29] on the extraction of
structurally analogous aminooxy probe (QDA)-carbonyl metabolite adducts.
Profiling thiol metabolites in A549 cells
Human lung adenocarcinoma A549 cells were simultaneously quenched and derivatized
with equimolar mixtures of QDE and *QDE in acetonitrile at pH 4 and 7.4 and then
analyzed as described in the “Materials and methods” section. This direct, in situ quench
approach allows for the rapid S-alkylation of labile thiols prior to their oxidations to
corresponding disulfides. Analyses of the FT-ICR-MS data of the adducts after applying the
described filters (noise removal and similar ion counts of m/z and m/z+4.02188) provided a
list of accurate masses of QDE adducts from which metabolite formulae were obtained and
then used to query the HMDB database. The profiling experiments were performed 4× for
each pH condition. We identified 12 metabolite masses that passed the filter criteria in at
least two out of four experiments at a given pH, which are listed in Table 1. The structural
assignments for the highest ion count metabolites (entries 1–3) are in agreement with the
chemoselectivity of QDE, namely the 4/4 hit rate at pH 4 strongly supports the thiol
assignments. Indeed, CID MS/MS analyses confirmed the structural assignments as
cysteine, cysteinylglycine, and glutathione (Fig. 5), respectively, see Electronic
Supplementary Material Figs. S17 and S20. These thiols have been documented previously
as major thiol metabolites [47]. Their relative abundance is nearly tenfold higher than that of
other thiol metabolites, as can be seen in a representative mass spectrum (Fig. 6) that shows
the ion count matching of the QDE and *QDE adduct pairs. Due to the high ion count of
these metabolites, we were able to confirm the 34S isotope incidences at ~4 % of the
respective 32S adducts. The sodiated C-terminal peaks for the glutathione adduct were also
observed.
Entries 4–6 (Table 1) are low-to-moderate abundant metabolites that were also assigned as
containing nucleophilic sulfur based on the observed reactivity with QDE at pH 4. Whereas
hypotaurine (Fig. 5), a sulfinic acid intermediate of taurine biosynthesis [48], is not a thiol, it
reacts similarly due to the nucleophilicity of the sulfinic sulfur atom [49]. The assignments
of hypotaurine and homocysteine (entries 4 and 5) were confirmed using CID MS/MS
analysis, see Electronic Supplementary Material Figs. S18 and S19. Interestingly, the lack of
adduct formation at pH 4 for the metabolites of entry 7 is consistent with the highly labile
nature of succinyldihydrolipoamide, an intermediate involved in the transfer of a succinyl
group from oxoglutarate via the oxoglutarate dehydrogenase complex (α-ketoglutarate
dehydrogenase complex) [50]. This adduct was registered only under pH 7.4 conditions at
which thiol alkylation occurs readily, while at pH 4, this reaction occurred at a slower rate
and presumably hydrolysis of the labile thioester bond in succinyldihydrolipoamide
prevented the buildup of the adducts to detectable levels. The lack of QDE adduct formation
at pH 4 for the metabolites of entries 8–11 suggests that these are either highly labile
metabolites or, more likely, non-thiol metabolites. The most probable HMDB-based
assignments for these entries are given except for entry 11 for which more than ten
possibilities exist. The value of performing thiol profiling at both pH 4 and 7.4 is further
noted when comparing the reactivity of the entry 8 metabolite—the lack of adduct
appearance at pH 4 suggests that the sulfur in this C5H9NO4S metabolite is not a free
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sulfhydryl. Rather, adduct formation is likely a result of carboxylate alkylation, hence its
putative assignment as the S-ether [51, 52]. The same is true for the C6H13NO2S metabolites
of entry 10, also putatively assigned as S-alkylated thiols [53, 54].
Quantification of cellular glutathione
To illustrate the value of the QDE/*QDE technique in quantifying biological thiols, we
selected glutathione as a representative example. The challenge in accurately quantifying
glutathione is to measure both its oxidized and reduced states, and to do this, it is necessary
to both quench any artifactual oxidation of GSH to GSSH by direct in situ derivatization as
illustrated above, and to exhaustively reduce GSSG. For the latter, commonly used reducing
agents include TCEP·HCl [55, 56], dithiothreitol (DTT) [57], trialkylphosphines [58],
NaBH4 [59], and occasionally sulfites, cyanides, or some enzymes. We selected the
TCEP·HCl reagent because it eliminates the complication of added thiol reagents, as with
the use of DTT, and the possibility of overreduction, as often the case with using NaBH4.
We were gratified to find an added benefit in using TCEP·HCl in that it reacted with the
iodoacetamide group of QDE to form the adduct of iodide displacement [60, 61]. Thus, after
reduction of glutathione disulfide using TCEP·HCl, excess QDE was added to capture the
newly reduced GSH as well as to consume the excess TCEP·HCl. The resultant [QDE-
TCEP]+ adduct (m/z 547.3512) was readily eliminated at the ion trap stage of the FT-ICR-
MS thus enabling tuning of the ion abundance targets (called AGC targets) to optimize the
spectra.
We also prepared [*QDE-GSH]+ to serve as an isotopic internal standard for intensity
normalization and quantification purposes. Increasing concentrations of [*QDE-GSH]+ were
added to the cellular extracts to establish calibration curves while nullifying interferences
from cell matrices. This also accommodated for any sodiation of the adduct in the extracts
being analyzed. We found the linear range for quantification to be between 0.04 and 5.00
μM of [*QDE-GSH]+ with regression (R2) values consistently over 99 % for three replicate
experiments (Fig. 7). The quantification of GSH and GSSG was thus carried out within this
range. Three plates were analyzed and each extract was quantified three times to ensure
reproducibility of the quantification results. Total concentrations of [GSH] and [GSSG]
were determined as 34.4± 11.5 and 10.1±4.0 nmol/mg protein, respectively. Whereas the
GSSG concentration in A549 cells has not been reported previously, our measured GSH
concentration in this cell line agrees with the GSH concentration of 30.1±1.5 nmol/mg
protein recently reported by Spadaro et al. [62]. In contrast, the GSH concentrations
measured in surgically resected human lung tumors of eight patients, also adenocarcinoma,
averaged 8.8±1.0 nmol/mg protein [63]. The lower value in this case is not unexpected due
to the likely factors of cancerous cell heterogeneity in tumor tissues and/or the rapid GSH/
GSSG perturbations during cell lysis that were not taken into consideration. The direct in
situ quench method shown here avoids such perturbations and allows for more accurate
quantification. Our results matched the quantification figures obtained by Spadaro et al. who
also took special care to avoid GSH/GSSG perturbations during cell lysis.
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Conclusion
We have illustrated an experimentally convenient approach to profile cellular thiols with
structural confirmation. Addition of the ammonium α-iodoacetamide reagent QDE and its
isotopologue *QDE directly to live cells followed by n-BuOH extraction and direct
electrospray FT-ICR-MS analysis provides a registry of isotopologue pairs. The probe
design and experimental protocol coupled with the high mass accuracy and ultra-high
resolution of FT-ICR-MS enable determination of metabolite molecular formulae. Equally
important is the enhanced chemoselectivity of QDE when cell extracts were reacted at pH 4,
thereby better delineating thiol from non-thiol metabolites. Our analysis of A549 cell
extracts revealed the major thiols to be glutathione, cysteine, and cysteinylglycine. We also
observed, for the first time, S-alkylated hypotaurine. Finally, QDE and *QDE were readily
applied for thiol quantification, such as demonstrated for the quantifications of glutathione
and glutathione disulfide. We showed this approach to be sensitive at the 40-nM range and
linear in the concentration range of 0.04 to 5.0 μM with >99 % accuracy. In summary, the
present approach should enable high sample and information throughput for profiling
cellular thiols as well as facilitate their quantification.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Structure and functional domains of CS reagent QDE
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Fig. 2.
Protocols for cellular extraction and analysis of [QDE/*QDE-thiol]+ adducts including
quantification of cellular GSH and GSSG. For detailed procedures, see Electronic
Supplementary Material
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Fig. 3.
Structural motifs and representative reagents for the select derivatization of thiols
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Fig. 4.
Ion trap mass spectrum of product mixture obtained from reaction of QDE with GSH in pH
8 potassium phosphate buffer for 12 h
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Fig. 5.
Confirmed thio-metabolites identified using the paired QDE/*QDE approach (neutral
configurations depicted, nucleophilic center indicated)
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Fig. 6.
Mass spectrum obtained from n-BuOH extract of A549 cells treated with QDE/*QDE
(blue=[QDE-thiol]+ adduct, red=[*QDE-thiol]+ adduct) at pH 7.4. The three high ion count
abundant [QDE-thiol]+ adducts are identified
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Fig. 7.
Quantification of GSH and GSSG in A549 cells. Linear ranges for detection of GSH (◆)
and GSSG (▲) were established using [*QDE-GSH]+ adduct as a standard. The [GSH] (■)
and [GSSG] (●) concentrations were measured (n=3) from 145 μL aliquots taken from the
n-BuOH supernatants at stages § and §§ (Fig. 2) for GSH and GSSG, respectively
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Scheme 1.
Reagents and conditions: a 1-iodododecane, CH3CN, 100 °C, 20 h; b H2NNH2·H2O, EtOH,
40 °C, 12 h, 83 % (two steps); c chloroacetyl chloride, K2CO3, CH2Cl2, rt, 12 h; d NaI,
acetone, 65 °C (sealed tube), 20 h, 78 % (two steps)
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Scheme 2.
Reagents and conditions: a 1-bromododecane, Na2CO3,
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